Cardiovascular Group of Syracuse — Liverpool, New York

Cardiovascular Group of Syracuse is a clinical research site located in Liverpool, New York, United States 13088.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Cardiovascular Group of Syracuse has participated in 1 clinical trials.

Therapeutic areas: Heart Failure, Tachycardia, Ventricular.

Sponsors: Abbott Medical Devices.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cardiovascular Group of Syracuse?

Cardiovascular Group of Syracuse has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cardiovascular Group of Syracuse conducted?

Cardiovascular Group of Syracuse has 1 clinical trials on record. Their work covers Heart Failure, Tachycardia, Ventricular.

Is Cardiovascular Group of Syracuse accredited by Crixeo Health?

Cardiovascular Group of Syracuse has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cardiovascular Group of Syracuse?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.